Case Updates
On September 1, 2026, the United States District Court for the Middle District of Tennessee granted preliminary approval of a settlement agreement resolving the derivative action, under which defendants have agreed to implement various corporate reforms and pay $12 million to Acadia Healthcare.
On August 24, 2026, the United States District Court for the Southern District of California granted preliminary approval of a settlement resolving the derivative action, under which defendants have agreed to implement various corporate reforms.
On August 12, 2026, the Delaware Court of Chancery denied defendants’ motion to dismiss a merger class action where KSF is acting as sole lead counsel.
On August 11, 2026, the United States District Court for the District of Minnesota largely denied defendants’ motion to dismiss the amended complaint in an ERISA class action.
In an amended complaint filed on July 9, 2026, plaintiffs allege that Dell and certain of its officers and directors breached their fiduciary duties and seek over $270 million in alleged damages.
On July 8, 2026, the United States District Court for the Southern District of New York denied defendants’ motion to dismiss in a securities class action where KSF is acting as Co-Lead Counsel.
Plaintiffs allege that Gemini and certain of its executives have violated federal securities laws by making misrepresentations and omissions regarding their intention to prioritize a prediction markets business instead of their existing cryptocurrency platform.
In a complaint filed on May 22, 2026, plaintiffs allege that Aon and certain of its officers and directors breached their fiduciary duties and seek over $120 million in alleged damages.
In an order entered on May 21, 2026, the Delaware Court of Chancery stayed a shareholder derivative action brought by KSF on behalf of Acadia Healthcare in light of the parties’ agreement in principle to settle the claims asserted therein and in certain related derivative actions.
In a status report filed on May 19, 2026, the parties to a shareholder derivative action brought on behalf of Acadia Pharmaceuticals in California federal court advised that they had substantially completed documenting a settlement of the claims asserted therein and in certain related stockholder demands, including a stockholder demand served by KSF.
KSF filed an ERISA class action complaint on April 17, 2026, against Providence Health & Services, St. Joseph Health System, and certain of their officers and directors alleging that defendants breached their fiduciary duties.
Vice Chancellor Nathan A. Cook denied the defendants’ motion to dismiss KSF’s class action complaint in its entirety. KSF’s complaint, filed in the Delaware Court of Chancery on behalf of former stockholders of Trecora Resources Inc., alleges that Trecora’s directors breached their duty of loyalty in connection with the sale of Trecora.
Plaintiffs allege that defendants breached their fiduciary duties by, among other things, failing to divest underperforming investments, engaging in transactions prohibited by ERISA.
Plaintiffs allege that defendants breached their fiduciary duties by, among other things, failing to divest underperforming investments, engaging in transactions prohibited by ERISA.
On October 22, 2025, the Hon. Jesus G. Bernal denied CoStar defendant’s motion to dismiss a data privacy class action complaint. The suit alleges that CoStar installed trackers on its websites that collected and shared users’ personal information.
After more than four years of litigation, the Hon. Maxine Chesney entered a Final Judgment approving a $27.5 million settlement for the Class in a Class action against Aimmune Therapeutics.
On December 18, 2024, a Final Judgment of $189 million settlement of the Class’s claims in Dicker v. TuSimple Holdings, Inc. et al., was approved.
The Hon. Roger T. Benitez preliminarily approved a $189,000,000 class action settlement in the TuSimple securities class action.
The Hon. Susan Illston entered a Final Judgment approving a $27.5 million settlement of the Class’s claims in the Velodyne Lidar litigation.
The Hon. Cynthia Bashant entered a Final Judgment approving a $7.75 million settlement in a Class action for breach of federal securities laws relating to a proposed merger of pharmaceutical company GW Pharmaceuticals.